INBS

Intelligent Bio Solutions (INBS)

Intelligent Bio Solutions Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INBS

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/30	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/05/29	21 : 30	GlobeNewswire Inc.	Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/05/24	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/05/23	21 : 30	GlobeNewswire Inc.	Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective Solutions	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/05/21	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/05/17	21 : 30	GlobeNewswire Inc.	Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety Event	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/05/09	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/05/08	21 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/05/08	21 : 30	GlobeNewswire Inc.	Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/04/18	21 : 30	GlobeNewswire Inc.	Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/04/11	21 : 30	GlobeNewswire Inc.	Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/03/26	21 : 30	GlobeNewswire Inc.	Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/03/13	08 : 30	GlobeNewswire Inc.	Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/03/11	21 : 30	GlobeNewswire Inc.	Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/03/05	07 : 26	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/03/02	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/03/01	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/28	22 : 30	GlobeNewswire Inc.	Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/21	07 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/16	22 : 30	GlobeNewswire Inc.	Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity Requirement	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/15	08 : 04	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/14	10 : 08	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/10	07 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/09	22 : 31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/09	22 : 30	GlobeNewswire Inc.	Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/08	07 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/06	06 : 18	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/05	23 : 00	GlobeNewswire Inc.	Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross Proceeds	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/03	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INBS	Intelligent Bio Solutions Inc
2024/02/02	22 : 30	GlobeNewswire Inc.	Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue Results	NASDAQ:INBS	Intelligent Bio Solutions Inc